SCIACCA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 4.152
EU - Europa 2.260
AS - Asia 1.491
SA - Sud America 257
AF - Africa 242
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 8.413
Nazione #
US - Stati Uniti d'America 3.970
SG - Singapore 848
IT - Italia 645
IE - Irlanda 574
CN - Cina 540
UA - Ucraina 451
BR - Brasile 239
CI - Costa d'Avorio 182
DE - Germania 181
CA - Canada 170
RU - Federazione Russa 147
SE - Svezia 77
SN - Senegal 39
FR - Francia 27
GB - Regno Unito 25
BE - Belgio 23
CH - Svizzera 21
CZ - Repubblica Ceca 20
IR - Iran 20
UZ - Uzbekistan 17
IN - India 16
VN - Vietnam 16
FI - Finlandia 15
AT - Austria 14
NL - Olanda 13
GR - Grecia 10
NG - Nigeria 10
TR - Turchia 8
AR - Argentina 7
EU - Europa 7
PL - Polonia 6
BG - Bulgaria 5
AU - Australia 4
LB - Libano 4
MX - Messico 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
BO - Bolivia 3
HK - Hong Kong 3
JP - Giappone 3
MA - Marocco 3
NO - Norvegia 3
VE - Venezuela 3
CO - Colombia 2
EC - Ecuador 2
EG - Egitto 2
IQ - Iraq 2
JM - Giamaica 2
TW - Taiwan 2
BD - Bangladesh 1
BH - Bahrain 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ES - Italia 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
Totale 8.413
Città #
Santa Clara 807
Dublin 562
Jacksonville 524
Chandler 484
Singapore 463
Chicago 255
Boardman 251
Catania 189
Abidjan 182
Nanjing 160
Cambridge 159
Lawrence 156
Andover 155
Toronto 138
Des Moines 99
Ashburn 92
Wilmington 82
Bremen 78
San Mateo 67
Civitanova Marche 65
Nanchang 55
Grafing 52
Hebei 46
Shenyang 45
Changsha 40
Dakar 39
Saint Petersburg 39
Ottawa 31
Quintano 30
Tianjin 30
Jiaxing 27
Munich 27
Brussels 23
Council Bluffs 22
Rome 21
Los Angeles 20
Beijing 18
Milan 18
Ardabil 17
Palermo 16
Brno 15
Moscow 15
São Paulo 15
Ann Arbor 14
Falls Church 14
Dong Ket 12
Norwalk 12
Pune 11
Seattle 11
Abuja 10
Washington 10
Gravina di Catania 9
Guangzhou 9
Lappeenranta 9
Portici 9
Bronte 8
Messina 8
Belo Horizonte 7
Giarre 7
Jinan 7
Leawood 7
Augusta 6
Den Haag 6
Helsinki 6
Kunming 6
Liberty Lake 6
Mascalucia 6
Pozzallo 6
Tashkent 6
The Dalles 6
Amsterdam 5
Hangzhou 5
Pescara 5
Taizhou 5
Tappahannock 5
Vienna 5
Zhengzhou 5
Agrigento 4
Campinas 4
Edinburgh 4
Hanoi 4
Houston 4
Istanbul 4
Porto Alegre 4
Reggio Calabria 4
San Francisco 4
Taggia 4
Abbiategrasso 3
Baku 3
Bologna 3
Carrara 3
Casalecchio di Reno 3
Cesa 3
Cochabamba 3
Enna 3
Esslingen am Neckar 3
Fiumicino 3
Florence 3
Fortaleza 3
Frankfurt Am Main 3
Totale 5.971
Nome #
La stimolazione con insulina o IGF-II delle isoforme A e B del recettore dell’insulina causa differenti effetti biologici in presenza di IRS-3 166
Body mass index is related to short term retinal worsening in type 2 diabetes patients treated with anticancer drugs 94
Different Effects of the Insulin Receptor Isoforms on 32D Cell Growth and Differentiation 84
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 84
Efficacy of real-time glucose continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial 84
Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels 83
Combined use of sonographic and elastosonographic parameters can improve the diagnostic accuracy in thyroid nodules at risk of malignancy at cytological examination 81
Short-term adverse effects of anticancer drugs in patients with type 2 diabetes 81
Insulin receptor isoforms in physiology and disease: An updated view 78
Adipose tissue, obesity and adiponectin: Role in endocrine cancer risk 77
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 76
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 72
Abnormal 1-hour post-load glycemia during pregnancy impairs post-partum metabolic status: a single-center experience 72
Papillary Thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries 71
Type 2 Diabetic patients with Graves' Disease have more frequent and severe Graves’ orbitopathy 71
Insulin receptor isoforms differently regulate cell proliferation and apoptosis in the ligand‐occupied and unoccupied state 71
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved 70
The IGF system in thyroid cancer:new concepts 70
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer 69
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 69
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 69
COVID-19 vaccination in pregnant and lactating diabetic women 68
Continuous subcutaneous insulin infusion (CSII) vs multiple daily insulin injections (MDI) in type 1 diabetes: effects on blood glucose variability 67
Infusione sottocutanea continua di insulina (CSII) e terapia insulinica multi-iniettiva (MDI) con glargine in pazienti con diabete mellito tipo 1 67
The isoform A of the insulin receptor as a regulator of the IGF system 67
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. 67
Comment on: Yang et al. (2010) Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry. Diabetes;59:1254-1260 66
ASPB(10) insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: Evidence for enhanced interactions with the insulin-like growth factor-I receptor 65
Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women 64
Impact of unhealthy childhood and unfavorable parents' characteristics on adiposity in schoolchildren 63
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 62
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism 62
Type I insulin-like growth factor receptor function in breast cancer 61
Analoghi dell’insulina in gravidanza: Sono utili? Sono sicuri? 61
Screening e diagnosi di diabete gestazionale 61
Insulin and its analogs:actions via insulin and IGF receptors 60
Diabete e contraccezione 60
In IGF-I receptor-deficient leiomyosarcoma cells autcrine IGF-II induces cell cell invasion and protection from apoptosis via the insulin receptor isoform A 60
ASPB10 insulin, a super analog of insulin, causes an increased mitogenic response and phenotypic changes in human breast epithelial cells 59
Confronto tra infusione sottocutanea continua di insulina (CSII) e terapia multiiniettiva (MDI) nel DM1: 5 anni di follow-up 59
Associazione tra alterata tolleranza ai carboidrati e sindrome metabolica in gravidanza 59
Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expression 59
Nuclear translocation of insulin receptor substrate-1 by the insulin receptor in mouse embryo fibroblasts 59
Insulin receptor isoforms in cancer 59
IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin binding 58
Studies of the purified fetal insulin receptor (IR-A) reveal that it is an IGF-II receptor 58
Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling 57
Signaling differences from the A and B isoforms of the insulin receptor in 32D cells in the presence or absence of IRS-1 57
Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling 57
Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells 57
Obesity, insulin-resistance and cancer 56
Diabetes and cancer 56
Differential Gene Expression Induced by Insulin-like Growth Factor-II through the Insulin Receptor Isoform A 56
Diabetes and Cancer 56
The role of insulin receptors and IGF-I receptors in cancer and other diseases 55
Diabetes and work: The need of a close collaboration between diabetologist and occupational physician 55
Insulin analogue effects through insulin receptor isoforms and IGF1R 54
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 54
Costruire un percorso assistenziale: investire per migliorare l'outcome e ridurre i costi 54
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease 54
Disordini del peso corporeo e del comportamento alimentare 53
Signaling Differences from the A and B isoforms of the Insulin Receptor (IR) in 32D Cells in the Presence or Absence of IR Substrate-1 53
Insulin-stimulated cell growth in insulin receptor substrate-1-deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase-independent pathway 53
Ruolo fisiologico della prima fase della secrezione insulinica 52
Donna con alterazioni della glicemia e aborti ripetuti 52
The insulin receptor isoform-A is a high affinity IGF-II receptor in human fetal cells 52
Measurement of IGF-1 receptor content in tissues and cell lines by radioimmunoassay (RIA) and ELISA techniques. 52
Progressione della retinopatia diabetica in soggetti in terapia insulinica con microinfusore o glargine: effetti del compenso e della variabilità glicemica 52
Screening and diagnosis of GDM: a new approach 52
Insulin receptors in breast cancer 52
Insulin receptor isoforms are differently expressed during human osteoblastogenesis 51
Screening and diagnosis of GDM: a new approach 51
Re:Insulin, Insulin-like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women 51
Screening e diagnosi del diabete gestazionale. 51
Do Nutrients and Nutraceuticals Play a Role in Diabetic Retinopathy? A Systematic Review 50
Insulin-like growth factor II stimulates cell growth through the insulin receptor in brest cancer: a newly identified autocrine/paracrine loop 50
Type 2 diabetes and cancer: problems and suggestions for best patient management 50
Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta 50
Epigenetic mechanisms in type 2 diabetes retinopathy: A systematic review 50
I nuovi criteri diagnostici hanno modificato l’impatto del diabete gestazionale? 49
Insulin/IGFs receptors interactions with insulin and insulin analogues in pregnancy 49
Good blood glucose control three years after giving birth in diabetic women treated with continuous subcutaneous insulin infusion (CSII) during pregnancy 49
Influence of Body Mass Index, Cancer Type and Treatment on Long-Term Metabolic and Liver Outcomes in Childhood Cancer Survivors 49
Insulin/IGF-I hybrid receptors are highly expressed in human breast cancer and are activated by IGF-I 48
Persistenza del buon compenso glicemico in donne con diabete pregravidico trattate con terapia insulinica sottocutanea continua (CSII) durante la gravidanza 48
Risk for Coexistent Autoimmune Diseases in Familial and Sporadic Type 1 Diabetes is Related to Age at Diabetes Onset 48
Insulin receptor A and B isoforms in 32D cells: signaling differences in the presence or absence of IRS-1 47
Monitoraggio in continuo del glucosio (CGM) in donne con diagnosi di diabete gestazionale suddivise in base al BMI pregravidico 47
Parametri predittivi per lo sviluppo del diabete mellito tipo 2 in donne con pregresso diabete gestazionale 47
Valori della glicemia a digiuno e HOMA-IR come semplici, indipendenti ed aggiuntivi fattori di rischio per diabete gestazionale e sindrome metabolica post-partum 47
Glicemia 1 h dopo carico orale di glucosio in donne normotolleranti con pregresso diabete gestazionale 47
Studio delle relazioni struttura/funzione della Tireoperossidasi (TPO) 47
An observational study comparing Continous Subcutaneous Insulin Infusion (CSII) and insulin glargine in type 1 diabetes 47
Obesity and cancer 47
The novel loss of function Ile354Val mutation in PPARG causes familial partial lipodystrophy 47
La persona con diabete in ospedale 47
Efficacia del monitoraggio glicemico real-time sul compenso e sulla variabilità glicemica di pazienti con diabete mellito tipo 1 instabile 46
Insulin and IGF-II stimulation of A and B insulin receptor isoforms mediates a different biological response in the presence of IRS-3 46
Insulin degludec in the first trimester of pregnancy: Report of two cases 46
Signaling differences in the A and B isoforms of the insulin receptor in 32D cells stimulated by either insulin or IGF-II in the presence of IRS-3 46
Totale 5.992
Categoria #
all - tutte 34.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020122 0 0 0 0 0 0 0 0 0 0 86 36
2020/2021886 13 68 110 11 217 26 110 8 115 5 161 42
2021/20221.164 142 164 10 18 187 9 174 42 97 0 45 276
2022/20231.776 175 47 20 235 154 328 1 293 413 21 56 33
2023/2024855 41 176 32 36 33 143 16 54 5 25 149 145
2024/20252.861 30 511 172 174 724 330 89 161 222 447 1 0
Totale 8.702